The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung
$ 24.00 · 5 (437) · In stock
The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung
Utility of needle biopsy in centrally located lung cancer for
Division of Cancer Immunology
医药前沿nature发文：CLIP1-LTK 融合基因-非小细胞肺癌的新治疗靶点
PDF) ALK, ROS1, RET and NTRK1–3 Gene Fusions in Colorectal and Non
Rare molecular subtypes of lung cancer
Identification of Ultrasound-Sensitive Prognostic Markers of LAML
Frontiers Cancer/Testis Antigens as Biomarker and Target for the
Genotype-phenotype mapping of a patient-derived lung cancer
Genotype-phenotype mapping of a patient-derived lung cancer
Frontiers Recent progress in targeted therapy for non-small cell
AMG-510 and cisplatin combination increases antitumor effect in
科学家揭示非小细胞肺癌新的驱动因素与药物靶点- 专区- 生物谷